In This Article:
Most investors find it challenging to find companies with prospective double-digit growth rates that are also financially robust. These hidden gems also add meaningful upside to a portfolio, should the companies meet expectations. If a buoyant growth prospect is what you’re after in your next investment, I’ve put together a list of high-growth stocks you may be interested in, based on the latest financial data from each company.
China Pioneer Pharma Holdings Limited (SEHK:1345)
China Pioneer Pharma Holdings Limited, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices in the People’s Republic of China, South East Asia, Europe, and Africa. Started in 1996, and run by CEO Mengjun Zhu, the company currently employs 340 people and with the market cap of HKD HK$3.09B, it falls under the mid-cap stocks category.
Driven by the positive double-digit sales growth of 39.05% over the next few years, 1345 is expected to deliver an excellent earnings growth of 15.62%. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 26.75%. 1345’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. Considering 1345 as a potential investment? I recommend researching its fundamentals here.
Zhongsheng Group Holdings Limited (SEHK:881)
Zhongsheng Group Holdings Limited, an investment holding company, engages in the sale and service of motor vehicles. Formed in 1998, and now run by Guoqiang Li, the company size now stands at 21,259 people and with the company’s market capitalisation at HKD HK$43.94B, we can put it in the large-cap group.
Extreme optimism for 881, as market analysts projected an outstanding earnings growth rate of 17.22% for the stock, supported by a double-digit sales growth of 30.17%. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 21.81%. 881’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. Considering 881 as a potential investment? Take a look at its other fundamentals here.